- Screening
- Baseline
- In the process of the treatment
- At the end of the treatment
- Follow-up 1
- Follow-up 2
- Follow-up 3
- Management system of participants
- Speciman management system
- Data management system
- ADR/ADE management system
- Madicine management system
- Instruments management system
- SOPs
- Research team
- Design, Methods
- Management of the progress
- General information
- Physical examination
- Blood Routine Tests
- Urine and Stool Routine Tests
- Blood Electrolytes Tests
- Coagulation Function Tests
- Serum Liver Function Tests
- HBV Markers Test
- Renel Function Test
- Heat Function Examination
- Blood Cell Morphology
- Image Examinations
- Nervous System Examination
- Lung Function Examination
- Blood Gas Analysis
- Physical Ability Examination
- Health Relative Quality of Life
Weight (week 2) | 69.0 |
Height (start) | 158.5 |
diastolic pressure (start) | 89 |
systolic pressure (start) | 135 |
BMI (start) | 27.4 |
Weight (start) | 68.9 |
BMI (week 4) | 27.5 |
Weight (week 2) | 69.0 |
BMI (week 2) | 27.5 |
IFABP (start) | 1.5 |
TNF-a (start) | 1.0 |
IL-6 (start) | 1.0 |
HbA1C (start) | 6 |
GLU-2hr (start) | 141 |
GLU-AC (start) | 121 |
TG (start) | 99 |
- Management for Progress
- Physical examination
- Blood Routine Tests
- Urine and Stool Routine Tests
- Serum Electrolytes Tests
- Liver Function Tests
- HBV Markers Test
- Renel Function Test
- Heat Function Examination
- Image Examinations
- Blood Cell Morphology
- Nervous System Examination
- Lung Function Examination
- Blood Gas Analysis
- Physical Sbility Examination
- Health Relative Quality of Life
diastolic pressure (week 6) | 78.0 |
systolic pressure (week 6) | 121.0 |
BMI (week 6) | 26.6 |
Weight (week 6) | 66.9 |
IFABP (end) | 1.8 |
TNF-a (end) | 1.9 |
IL-6 (end) | 1.5 |
HbA1C (end) | 6.0 |
GLU-2hr (end) |
|
GLU-AC (end) | 108.0 |
TG (end) | 76.0 |